Listen on the go
CORRECT!
Next question
touchNEUROLOGY touchNEUROLOGY

Start Learning

Touch Loading image
JOURNALS
Start Learning
Intrathecal onasemnogene abeparvovec shows promise in older children with SMA
JOURNALS
Start Learning
Prenatal treatment for SMA shows promise in groundbreaking case report
JOURNALS
Start Learning
European experts release updated consensus on gene therapy for spinal muscular atrophy: Key recommendations for treatment
touchMEETING HIGHLIGHTS
Start Learning
The complicated journey to Friedreich ataxia diagnosis
Sponsored content
JOURNALS
Start Learning
Future directions in psychiatry with Dr Alexander Lisinski: touchNEUROLOGY Future Leader 2025
touchFEATURE
Start Learning
The use of biomarkers for the accurate and timely diagnosis of Alzheimer’s disease in clinical practice
Sponsored content
JOURNALS
Start Learning
A Review of Hyaluronidase-facilitated Subcutaneous Immunoglobulin 10% as Maintenance Therapy for Chronic Inflammatory Demyelinating Polyradiculoneuropathy
JOURNALS
Start Learning
Nipocalimab for generalized myasthenia gravis: First FcRn blocker approved for broad adult population
journal placeholder
JOURNALS
Start Learning
Prof. Konstantin Slavin leads the future of neuromodulation as new INS President
JOURNALS
Start Learning
Perspectives on psychiatric care with Dr Anna Laure: touchNEUROLOGY Future Leader 2025

to view Favourites, Keep Notes and Track CME Credits

Favourites
EAN 2024: Symposium highlights from Helsinki
View
Prof. Konstantin Slavin leads the future of neuromodulation as new INS President
View
Friedreich ataxia – from genetic mutations to clinical symptoms
View
Expanding horizons for patients with Pompe disease: Using data to guide clinical practice
View
Therapeutic Approaches for the Treatment of Chorea in Huntington’s Disease
View
Let’s talk about agitation in Alzheimer’s dementia: Prevalence, behavioural symptoms and reaching a diagnosis
View
Understanding Microglia: A Key Driver of Smoldering Neuroinflammation
View
Insights into evolving needs of patients with SMA as they age: claims data and expert opinion
View
Past Successes & Future Innovations in MS: Taking on Disability Accumulation Through Personalised Care, Biomarkers, and Clinical Trial Design
View
Movement disorders at EAN 2024: Key highlights and beyond
View
Copied to clipboard!
accredited arrow-down-editablearrow-downarrow_leftarrow-right-bluearrow-right-dark-bluearrow-right-greenarrow-right-greyarrow-right-orangearrow-right-whitearrow-right-bluearrow-up-orangeavatarcalendarchevron-down consultant-pathologist-nurseconsultant-pathologistcrosscrossdownloademailexclaimationfeedbackfiltergraph-arrowinterviewslinkmdt_iconmenumore_dots nurse-consultantpadlock patient-advocate-pathologistpatient-consultantpatientperson pharmacist-nurseplay_buttonplay-colour-tmcplay-colourAsset 1podcastprinter scenerysearch share single-doctor social_facebooksocial_googleplussocial_instagramsocial_linkedin_altsocial_linkedin_altsocial_pinterestlogo-twitter-glyph-32social_youtubeshape-star (1)tick-bluetick-orangetick-red tick-whiteticktimetranscriptup-arrowwebinar Sponsored Department Location NEW TMM Corporate Services Icons-07NEW TMM Corporate Services Icons-08NEW TMM Corporate Services Icons-09NEW TMM Corporate Services Icons-10NEW TMM Corporate Services Icons-11NEW TMM Corporate Services Icons-12Salary £ TMM-Corp-Site-Icons-01TMM-Corp-Site-Icons-02TMM-Corp-Site-Icons-03TMM-Corp-Site-Icons-04TMM-Corp-Site-Icons-05TMM-Corp-Site-Icons-06TMM-Corp-Site-Icons-07TMM-Corp-Site-Icons-08TMM-Corp-Site-Icons-09TMM-Corp-Site-Icons-10TMM-Corp-Site-Icons-11TMM-Corp-Site-Icons-12TMM-Corp-Site-Icons-13TMM-Corp-Site-Icons-14TMM-Corp-Site-Icons-15TMM-Corp-Site-Icons-16TMM-Corp-Site-Icons-17TMM-Corp-Site-Icons-18TMM-Corp-Site-Icons-19TMM-Corp-Site-Icons-20TMM-Corp-Site-Icons-21TMM-Corp-Site-Icons-22TMM-Corp-Site-Icons-23TMM-Corp-Site-Icons-24TMM-Corp-Site-Icons-25TMM-Corp-Site-Icons-26TMM-Corp-Site-Icons-27TMM-Corp-Site-Icons-28TMM-Corp-Site-Icons-29TMM-Corp-Site-Icons-30TMM-Corp-Site-Icons-31TMM-Corp-Site-Icons-32TMM-Corp-Site-Icons-33TMM-Corp-Site-Icons-34TMM-Corp-Site-Icons-35TMM-Corp-Site-Icons-36TMM-Corp-Site-Icons-37TMM-Corp-Site-Icons-38TMM-Corp-Site-Icons-39TMM-Corp-Site-Icons-40TMM-Corp-Site-Icons-41TMM-Corp-Site-Icons-42TMM-Corp-Site-Icons-43TMM-Corp-Site-Icons-44TMM-Corp-Site-Icons-45TMM-Corp-Site-Icons-46TMM-Corp-Site-Icons-47TMM-Corp-Site-Icons-48TMM-Corp-Site-Icons-49TMM-Corp-Site-Icons-50TMM-Corp-Site-Icons-51TMM-Corp-Site-Icons-52TMM-Corp-Site-Icons-53TMM-Corp-Site-Icons-54TMM-Corp-Site-Icons-55TMM-Corp-Site-Icons-56TMM-Corp-Site-Icons-57TMM-Corp-Site-Icons-58TMM-Corp-Site-Icons-59TMM-Corp-Site-Icons-60TMM-Corp-Site-Icons-61TMM-Corp-Site-Icons-62TMM-Corp-Site-Icons-63TMM-Corp-Site-Icons-64TMM-Corp-Site-Icons-65TMM-Corp-Site-Icons-66TMM-Corp-Site-Icons-67TMM-Corp-Site-Icons-68TMM-Corp-Site-Icons-69TMM-Corp-Site-Icons-70TMM-Corp-Site-Icons-71TMM-Corp-Site-Icons-72
Close Popup